CSGCX
Price
$44.56
Change
-$0.22 (-0.49%)
Updated
Nov 14 closing price
RLBEX
Price
$36.39
Change
-$0.17 (-0.46%)
Updated
Nov 14 closing price
Ad is loading...

CSGCX vs RLBEX

Header iconCSGCX vs RLBEX Comparison
Open Charts CSGCX vs RLBEXBanner chart's image
Calvert Balanced C
Price$44.56
Change-$0.22 (-0.49%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R4
Price$36.39
Change-$0.17 (-0.46%)
VolumeN/A
CapitalizationN/A
CSGCX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSGCX vs. RLBEX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSGCX is a Buy and RLBEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 239B vs. CSGCX (1.34B). RLBEX pays higher dividends than CSGCX: RLBEX (2.24) vs CSGCX (1.64). CSGCX was incepted earlier than RLBEX: CSGCX (31 years) vs RLBEX (22 years). RLBEX is a more actively managed with annual turnover of: 171.00 vs. CSGCX (106.00). RLBEX has a lower initial minimum investment than CSGCX: RLBEX (250) vs CSGCX (1000). CSGCX annual gain was more profitable for investors over the last year : 25.56 vs. RLBEX (22.61). RLBEX (37.47) and CSGCX (37.12) have equivalent 5 years return.
CSGCXRLBEXCSGCX / RLBEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years22 years-
Gain YTD19.40915.577125%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.34B239B1%
Annual Yield % from dividends1.642.2474%
Returns for 1 year25.5622.61113%
Returns for 3 years7.9811.9267%
Returns for 5 years37.1237.4799%
Returns for 10 years44.5655.1081%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VINE0.690.06
+9.54%
Fresh Vine Wine
QIPT2.770.07
+2.41%
Quipt Home Medical Corp
SEB2716.0951.37
+1.93%
Seaboard Corp
MRNA42.14-1.33
-3.06%
Moderna
REPL11.69-0.50
-4.10%
Replimune Group